ubmslateRN-logo-ubm

RN Mobile Menu

Search form

Topics:

Lupus

Lupus

The lack of progress in new treatments for lupus nephritis summarized in this scientific review.

(Meningitis bacteria ©EzumeImages/Shutterstock.com)

Cryptococcal meningitis infections in systemic lupus erythematosus (SLE) patients often go misdiagnosed, researchers find.

Bone with osteoperosis (©Lightspring/Shutterstock.com)

Low bone mineral density and osteoporosis are well-known comorbidities with systemic lupus erythematosus. In this slideshow, we highlight six of the most common risk factors for low bone mineral density in SLE.

©Lightspring/Shutterstock.com

Age and cumulative glucocorticoid exposure are key risk factors for low bone mineral density in systemic lupus erythematosus.

(©Wallybird/Shutterstock.com)

For high risk patients with systemic lupus erythematosus, teriparatide and denosumab may be an option for patients who have failed bisphosphonates. Here are some key points you need to know.

©donskarpo/Shutterstock.com

Bone loss could affect as many as 31 percent of SLE patients. This article sums up the treatment options from first-line bisphosphonate recommendations to emerging treatments like abaloparatide.

(©docstockmediaShutterstock.com)

It can take as long as five years for patients presenting symptoms of systemic lupus erythematosus (SLE) to get a definitive diagnosis.

Pages

Subscribe to Lupus on [sitename]

By clicking Accept, you agree to become a member of the UBM Medica Community.